Literature DB >> 20139038

Chromatin dynamics during herpes simplex virus-1 lytic infection.

Brandon J Placek1, Shelley L Berger.   

Abstract

Herpes simplex virus type 1 is a DNA virus that can establish lytic infections in epithelial cells and latent infections in sensory neurons. Upon entry into the nucleus the genome of HSV-1 rapidly associates with histone proteins. Similar to the genomes of the cellular host, HSV-1 is subject to chromatin-based regulation of transcription and replication. However, unlike the host genome, nucleosomes appear to be underrepresented on the HSV genome. During lytic infection, when the genome is transcribed, the HSV-1 chromatin structure appears to be disorganized, and characterized by histone variant sub-types and post-translational modifications representative of active chromatin. In contrast, during latency, when the majority of the viral genome is transcriptionally silent, the chromatin is compacted into a regularly repeating, compact heterochromatic structure. Here we discuss recent studies that underscore the importance of chromatin regulation during the lytic phase of the HSV-1 life-cycle. 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139038     DOI: 10.1016/j.bbagrm.2010.01.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  Histone H3 lysine 4 methylation marks postreplicative human cytomegalovirus chromatin.

Authors:  Alexandra Nitzsche; Charlotte Steinhäusser; Katrin Mücke; Christina Paulus; Michael Nevels
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

2.  Dynamic interactions between Bombyx mori nucleopolyhedrovirus and its host cells revealed by transcriptome analysis.

Authors:  Jian Xue; Nan Qiao; Wei Zhang; Ruo-Lin Cheng; Xiao-Qin Zhang; Yan-Yuan Bao; Yi-Peng Xu; Lin-Zhu Gu; Jing-Dong Jackie Han; Chuan-Xi Zhang
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Herpes simplex virus 1 DNA is in unstable nucleosomes throughout the lytic infection cycle, and the instability of the nucleosomes is independent of DNA replication.

Authors:  Jonathan J Lacasse; Luis M Schang
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

4.  Characterization of Elements Regulating the Nuclear-to-Cytoplasmic Translocation of ICP0 in Late Herpes Simplex Virus 1 Infection.

Authors:  Subodh Kumar Samrat; Binh L Ha; Yi Zheng; Haidong Gu
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

5.  Varicella zoster virus latency.

Authors:  Emily Eshleman; Aamir Shahzad; Randall J Cohrs
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

6.  Detection of the genome and transcripts of a persistent DNA virus in neuronal tissues by fluorescent in situ hybridization combined with immunostaining.

Authors:  Frédéric Catez; Antoine Rousseau; Marc Labetoulle; Patrick Lomonte
Journal:  J Vis Exp       Date:  2014-01-23       Impact factor: 1.355

7.  Chromatin assembly on herpes simplex virus 1 DNA early during a lytic infection is Asf1a dependent.

Authors:  Jaewook Oh; Nicholas Ruskoski; Nigel W Fraser
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

8.  Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells.

Authors:  Joseph A Hollenbaugh; Peter Gee; Jonathon Baker; Michele B Daly; Sarah M Amie; Jessica Tate; Natsumi Kasai; Yuka Kanemura; Dong-Hyun Kim; Brian M Ward; Yoshio Koyanagi; Baek Kim
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

9.  Tegument protein control of latent herpesvirus establishment and animation.

Authors:  Rhiannon R Penkert; Robert F Kalejta
Journal:  Herpesviridae       Date:  2011-02-08

10.  The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0.

Authors:  Caroline E Lilley; Mira S Chaurushiya; Chris Boutell; Roger D Everett; Matthew D Weitzman
Journal:  PLoS Pathog       Date:  2011-06-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.